NeuroOne stock is down on Q4 revenue misses
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast.
Source: massdevice.com
📰 Massdevice Medtech News
Page 5 - Massdevice Medtech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Massdevice Medtech. Real-time updates on events, politics, business and more.
Edwards plans to spin off critical care business next year
Edwards Lifesciences (NYSE:EW) announced today that it intends to spin off its critical care business by the end of 2024.
Source: massdevice.com
Medtronic's mid-single digit revenue growth continues
Medtronic reported Q2 that results beat The Street, with the medtech giant reporting strength across businesses and geographies.
Source: massdevice.com
FDA clears Masimo W1 medical watch
Masimo has received FDA 510(k) clearance for its Masimo W1 medical watch for both over-the-counter and prescription use.
United Kingdom Joe Kiani Massdevice Medtech Virtual Health Extraction Technology Department Of Anesthesiology
Source: massdevice.com
Alcon stock dips on Q3 misses, tightened guidance
Alcon shares fell this morning on third-quarter results that came up shy of the consensus forecast.
Source: massdevice.com
Vicarious Surgical has more layoffs, pushes surgical robot timeline
Vicarious Surgical pushed back expectations on the timeline for its surgical robot as it trimmed its headcount for the second time this year.
Source: massdevice.com
BD stock plummets on mixed Q4 results
BD (NYSE: BDX) shares took a hit this morning on fourth-quarter results that came in mixed compared to the consensus forecast.
Source: massdevice.com
Zimmer Biomet stock dips on Q3 beats, lowered sales guidance
Zimmer Biomet shares fell today on third-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com
ICU Medical stock falls on Q3 revenue miss
ICU Medical stock is down today after a third-quarter earnings report that included a revenue miss.
Source: massdevice.com
Insulet posts strong Q3, expects Dexcom G7 integration in 2024
Insulet (Nasdaq:PODD) shares got a boost after hours on third-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com